Finally, the analysis of intracellular signaling demonstrated that the PKA pathway is responsible for the A2AR-dependent effect on cholesterol accumulation since the PKA inhibitor KT5720, but not the ERK1/2 inhibitor PD98059, prevented the cholesterol redistribution induced by CGS21680 in NPC OPs. This evidence concerns the gene MAPK3 and nasopharyngeal carcinoma.